zafirlukast (Compound)

Synonyms:zafirlukast, 107753-78-6, Accolate, Olmoran, ICI-204219, Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate, Accoleit, ICI 204,219, ICI 204219, Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate

Pubchem:PUBCHEM:5717

Id:f5a7af4b-10f3-58e7-867d-4b9c07b2377d

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View zafirlukast's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for zafirlukast.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with zafirlukast.

Results found

Linked to

	Label	Description
	BRD-K71289571-001-11-4 Substance (Entity type)	A Substance
	zafirlukast in similarity relationship with Dicloxacillin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast bioactivity Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	zafirlukast indication Asthma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	zafirlukast negatively regulates THBS2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast negatively regulates NR3C1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast negatively regulates NPTX2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast negatively regulates SLC7A11 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast negatively regulates CXCL8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	zafirlukast negatively regulates CCL20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K71289571-001-11-4

Substance (Entity type)

A Substance

zafirlukast in similarity relationship with Dicloxacillin

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast bioactivity Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

zafirlukast indication Asthma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

zafirlukast negatively regulates THBS2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast negatively regulates NR3C1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast negatively regulates NPTX2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast negatively regulates SLC7A11

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast negatively regulates CXCL8

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

zafirlukast negatively regulates CCL20

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.